- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT06516653
Postmarkedsundersøgelse for VasQ, et eksternt støtteimplantat til arteriovenøs fistel
Postmarket-overvågning, prospektiv, multicenter, randomiseret, kontrolleret undersøgelse, der evaluerer VasQs ydeevne til dets tilsigtede brug.
VasQ is an external support implant for arteriovenous fistulas created for dialysis access.
This is a postmarket surveillance, prospective, multi-center, randomized, controlled, open label trial enrolling 300 patients randomized into two study arms:
- Treatment arm: End to side fistula supported with VasQ
- Control: Standard of care end to side fistula
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Structure
This is a postmarket surveillance, prospective, multi-center, randomized, controlled, open label trial enrolling 300 patients randomized into two study arms:
- Treatment arm: End to side fistula supported with VasQ
- Control: Standard of care end to side fistula
Duration The primary endpoint is defined at 6 month post index procedure of fistula creation. Patients will be further followed up to 12 months post index procedure.
Main study question What is the magnitude of benefit of the VasQ device with regard to time to achieving a clinically functional AVF as compared to a comparable contemporary standard of care cohort?
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Galit Itzhaki
- Telefonnummer: +972-3-6344246
- E-mail: galit@laminatemedical.com
Studiesteder
-
-
California
-
Long Beach, California, Forenede Stater, 90706
- Rekruttering
- Fresenius Vascular Care Long Beach
-
Kontakt:
- Deann Helton
- Telefonnummer: 562-888-8961
- E-mail: Deann.Helton@azuracare.com
-
Ledende efterforsker:
- Anthony Becker, MD
-
-
Florida
-
Sarasota, Florida, Forenede Stater, 34239
- Rekruttering
- Sarasota Memorial Health Care System
-
Ledende efterforsker:
- Jason Wagner, MD
-
Kontakt:
- Kaitlyn Meek, RN
- Telefonnummer: 941-917-7109
- E-mail: ResearchInstitute@smh.com
-
-
Georgia
-
Atlanta, Georgia, Forenede Stater, 30303
- Rekruttering
- Grady Memorial Hospital
-
Ledende efterforsker:
- Christopher Ramos, MD
-
Kontakt:
- Ronnie Adams
- Telefonnummer: 404-251-8984
- E-mail: rwadam2@emory.edu
-
Decatur, Georgia, Forenede Stater, 30033
- Rekruttering
- Atlanta VA Medical Center
-
Ledende efterforsker:
- Olamide Alabi, MD
-
Kontakt:
- Adriana Gutrierrez Yllu
- Telefonnummer: 404-729-6350
- E-mail: Adriana.Gutierrezyllu@va.gov
-
Kontakt:
- Maddie Sancheti
- Telefonnummer: 404-321-6111
- E-mail: madhur.sancheti@va.gov
-
-
Louisiana
-
New Orleans, Louisiana, Forenede Stater, 70121
- Rekruttering
- Ochsner Clinic Foundation
-
Kontakt:
- Shannon Williams
- Telefonnummer: 504-842-6487
- E-mail: slwilliams@ochsner.org
-
Ledende efterforsker:
- Waldemar Sternbergh, MD
-
-
Massachusetts
-
Boston, Massachusetts, Forenede Stater, 02115
- Rekruttering
- Brigham and Women's Hospital
-
Kontakt:
- Navya Kotturu
- Telefonnummer: 617-525-8555
- E-mail: nkotturu@bwh.harvard.edu
-
Kontakt:
- Danielle Montano
- Telefonnummer: 617-525-8555
- E-mail: dmontano2@bwh.harvard.edu
-
Ledende efterforsker:
- Mohamad Hussain, MD
-
-
Mississippi
-
Greenwood, Mississippi, Forenede Stater, 38930
- Rekruttering
- Greenwood Leflore Hospital
-
Kontakt:
- Kimberly McMillian
- Telefonnummer: 662-453-4641
- E-mail: kmcmillian@glh.org
-
Ledende efterforsker:
- John F Lucas, MD
-
-
Nevada
-
Las Vegas, Nevada, Forenede Stater, 99128
- Aktiv, ikke rekrutterende
- Azura Surgery Center Las Vegas
-
-
South Carolina
-
Columbia, South Carolina, Forenede Stater, 29203
- Rekruttering
- Fresenius Vascular Care Columbia
-
Kontakt:
- Alicia Phillips-Pough
- Telefonnummer: 803-252-3373
- E-mail: alicia.phillips-pough@azuracare.com
-
Kontakt:
- Tami Hardwick
- Telefonnummer: 803-252-3373
- E-mail: tami.hardwick@azuracare.com
-
Ledende efterforsker:
- Dion Franga, MD
-
-
Tennessee
-
Memphis, Tennessee, Forenede Stater, 38115
- Ikke rekrutterer endnu
- James E. Gardner MD, P.C.
-
Kontakt:
- Hannah Touliatos
- Telefonnummer: 901-604-0345
- E-mail: hannahgardner3@gmail.com
-
Ledende efterforsker:
- James Gardner, MD
-
Nashville, Tennessee, Forenede Stater, 37232
- Rekruttering
- Vanderbilt University Medical Center
-
Kontakt:
- Stephen R Gannon
- Telefonnummer: 615-936-6809
- E-mail: stephen.r.gannon@vumc.org
-
Ledende efterforsker:
- Robert Shahverdyan, MD
-
-
Texas
-
Houston, Texas, Forenede Stater, 77030
- Rekruttering
- Houston Methodist Hospital
-
Ledende efterforsker:
- Eric Peden, MD
-
Kontakt:
- Abhiraj Sinha
- Telefonnummer: 404-251-8984
- E-mail: asinha@houstonmethodist.org
-
-
Virginia
-
Roanoke, Virginia, Forenede Stater, 24014
- Rekruttering
- Fairlawn Surgery Center
-
Ledende efterforsker:
- Ryan Evans, MD
-
Kontakt:
- Aleisha Umber, RN
- Telefonnummer: 540-904-6170
- E-mail: AUMBER@FSCMED.COM
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Patients who are candidates for the creation of a new radiocephalic or brachiocephalic end-to-side surgical AV fistula for dialysis access (per VasQ IFU and investigator clinical judgment) and consent to take part in the study.
- Male and non-pregnant female participants.
- Age 18-80 years
- Patients willing and able (physically and geographically) to attend follow up visits over a period of 12 months.
Exclusion Criteria:
- Index procedure being a revision surgery of an existing fistula.
- Significantly stenotic target vein on the side of surgery (≥50%) as diagnosed on preoperative ultrasound. (Scan should include the full length of the expected fistula outflow, starting at the planned anastomosis site)
- Unusual anatomy or vessel dimensions (observed on pre-operative ultrasound or intraoperatively) and which preclude adequate fit of the VasQ.
- Known central venous stenosis or obstruction on the side of surgery.
- Pre-existing stents or stent grafts in the access circuit.
- Planned subsequent fistula superficialization procedure.
- Known coagulation disorder.
- Known allergy to nitinol.
- Expected kidney transplant within 12 months of enrollment.
- Inability to give consent and/or comply with the study follow up schedule.
- Insufficient or borderline life expectancy to allow for completion of study procedures and follow-up (12 Months).
- Participation in another interventional study that in the judgment of the investigator could confound study results.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: End to side fistula supported with VasQ
Patients receiving an end to side arteriovenous fistula, supported by VasQ, for fistula access |
External support implant for the arteriovenous fistula End to side fistula creation in the arm for dialysis vascular access |
|
Aktiv komparator: Standard of care end to side fistula
Patients receiving an end to side arteriovenous fistula, for fistula access |
End to side fistula creation in the arm for dialysis vascular access |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Fistula functional success
Tidsramme: 6 months
|
The time, in days, to the first day of a 28-day period in which the study fistula was able to be cannulated with two dialysis needles for at least 75% of dialysis sessions to achieve the prescribed dialysis |
6 months
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Safety - vascular access related complications
Tidsramme: 1 year
|
Comparable rate of access related complications (including major reintervention and cannulation related complications) |
1 year
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: John F Lucas III, MD FACS FSVS, Greenwood Leflore Hospital
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Urogenitale sygdomme
- Patologiske processer
- Mandlige urogenitale sygdomme
- Nyresygdomme
- Urologiske sygdomme
- Urogenitale sygdomme hos kvinder
- Kvinders urogenitale sygdomme og graviditetskomplikationer
- Kronisk sygdom
- Sygdomsegenskaber
- Nyreinsufficiens
- Nyreinsufficiens, kronisk
- Patologiske tilstande, tegn og symptomer
- Nyresvigt, kronisk
Andre undersøgelses-id-numre
- CD0261
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .